Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022Irina Kislaya, Aryse Melo, Marta Barreto et al.|Emerging infectious diseases|2023Cited by 9
SARS-CoV-2 Seroprevalence Following a Large-Scale Vaccination Campaign in Portugal: Results of the National Serological Survey, September - November 2021Irina Kislaya, Ana Rita Torres, Vânia Gaio et al.|Acta Médica Portuguesa|2022Cited by 5
End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in PortugalIrina Kislaya, National Influenza Surveillance Network, Ana Rita Torres et al.|Human Vaccines & Immunotherapeutics|2023Cited by 4
Nirsevimab Effectiveness Against RSV‐Related Hospitalisations in Children Under 24 Months: A Test‐Negative Case–Control Study in Portugal, 2024–2025Vânia Gaio, Camila Henriques, Miguel Lança et al.|Influenza and Other Respiratory Viruses|2025Cited by 2
Genetic and Epidemiological Insights Into Respiratory Syncytial Virus Infections: A Comparative Study of Hospitalized Versus Community Cases in Portugal (2021–2023)Miguel Lança, Aryse Melo, Vânia Gaio et al.|Influenza and Other Respiratory Viruses|2025Cited by 2